What Are the Challenges in Targeting Transcription in Cancer?
Despite its potential, targeting transcription in cancer presents several challenges. Transcription factors often lack well-defined binding pockets, making it difficult to design specific inhibitors. Moreover, the redundancy and complexity of transcriptional networks mean that inhibiting a single factor may not be sufficient to halt cancer progression. Therefore, combination therapies that target multiple aspects of transcriptional regulation may be necessary.
